0
Signin
countryflagUS

18889881171

AAPL 169.89 0.5147% MSFT 399.04 -2.4495% GOOG 157.95 -1.9553% GOOGL 156.0 -1.9669% AMZN 173.67 -1.6535% NVDA 826.32 3.7087% META 441.38 -10.5613% TSLA 170.18 4.9652% TSM 136.58 2.7149% LLY 724.87 -1.0011% V 275.16 0.0509% AVGO 1294.42 2.9917% JPM 193.37 0.1502% UNH 493.86 1.3462% NVO 125.79 -0.2933% WMT 60.21 0.5679% LVMUY 167.91 -2.1618% XOM 121.35 0.2478% LVMHF 837.0 -2.6461% MA 462.11 -0.0843%

Ampio Pharm

Healthcare US AMPE

0.35USD
-(-%)

Last update at 2024-04-25T18:48:00Z

Day Range

0.290.47
LowHigh

52 Week Range

1.737.95
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -16.33700M -17.07500M -15.89400M -13.63000M 33.99M
Minority interest - - - - -
Net income -8.46700M -12.48500M -16.49800M -8.68400M 33.99M
Selling general administrative 11.47M 8.67M 6.65M 5.90M 4.36M
Selling and marketing expenses - - - - -
Gross profit - - - - -0.52300M
Reconciled depreciation 1.05M 1.09M 1.18M 1.27M 1.28M
Ebit -24.20700M -25.15700M -15.21800M -23.44500M -56.35875M
Ebitda -23.15900M -24.06300M -14.04100M -22.17300M -55.07737M
Depreciation and amortization 1.05M 1.09M 1.18M 1.27M 1.28M
Non operating income net other - 3.49M -0.07200M 4.87M -
Operating income -24.20700M -25.15700M -15.21800M -23.44500M -11.18361M
Other operating expenses 20.38M 20.57M 15.83M 18.58M 11.18M
Interest expense -7.87000M 8.08M 0.00000M 0.08M 0.00501M
Tax provision - - - - -
Interest income 0.22M 0.00400M 0.01M 0.08M 0.00501M
Net interest income 0.22M 0.00400M 0.01M 0.08M -0.00501M
Extraordinary items - - - - -
Non recurring - - - - 0.12M
Other items - - - - -
Income tax expense -7.87000M -4.59000M 0.60M -4.94600M 45.17M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 20.38M 20.57M 15.83M 18.58M 11.18M
Cost of revenue - - - - 0.52M
Total other income expense net 7.87M 8.08M -0.67600M 9.81M 45.18M
Discontinued operations - - - - -
Net income from continuing ops -16.33700M -17.07500M -15.89400M -13.63000M -11.18396M
Net income applicable to common shares -16.33700M -17.07500M -15.89400M -13.63000M 33.99M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 13.59M 38.83M 22.88M 14.00M 14.03M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.62M 0.53M 0.70M 0.56M 0.41M
Total liab 1.80M 11.54M 5.37M 7.56M 8.79M
Total stockholder equity 11.79M 27.28M 17.51M 6.44M 5.24M
Deferred long term liab - 5.80M 2.61M 2.06M 7.41M
Other current liab 0.76M 4.38M 1.36M 3.87M 1.38M
Common stock 0.00200M 0.02M 0.02M 0.02M 0.01M
Capital stock 0.00200M 0.02M 0.02M 0.02M 0.01M
Retained earnings -233.93900M -217.60200M -200.52700M -184.63300M -171.00251M
Other liab 0.33M 5.80M 2.61M 2.06M 7.41M
Good will - - - - -
Other assets - 42.02M - - 0.00058M
Cash 12.65M 33.89M 17.35M 6.53M 7.59M
Cash and equivalents - - - - -
Total current liabilities 1.19M 5.12M 1.83M 4.28M 1.38M
Current deferred revenue - - - - -
Net debt -12.03900M -32.96700M -16.13700M -5.06300M -7.58539M
Short term debt 0.34M 0.31M 0.28M 0.26M -
Short long term debt - - - - -
Short long term debt total 0.61M 0.93M 1.21M 1.47M -
Other stockholder equity 245.73M 244.86M 218.02M 191.06M 181.02M
Property plant equipment 0.26M 2.56M 3.56M 4.75M 6.00M
Total current assets 13.33M 35.63M 18.49M 8.25M 8.00M
Long term investments - - - - -
Net tangible assets 11.79M 27.28M 17.51M 6.44M 5.24M
Short term investments - - - - -
Net receivables - 0.02M 0.18M 0.02M -
Long term debt - - - - -
Inventory 0.00000M 1.19M 0.27M - -
Accounts payable 0.10M 0.43M 0.19M 0.15M 1.32M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -6.06500M -4.79300M
Additional paid in capital - - - - -
Common stock total equity - 0.02M 0.02M 0.02M 0.01M
Preferred stock total equity - - - - -
Retained earnings total equity - -217.60200M -200.52700M -184.63300M -171.00251M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.63M 0.82M 1.00M 0.03M
Deferred long term asset charges - - - - -
Non current assets total 0.26M 3.19M 4.38M 5.75M 6.03M
Capital lease obligations 0.61M 0.93M 1.21M 1.47M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.00000M -0.09700M -0.06300M -0.02200M -0.56428M
Change to liabilities -3.95900M 3.26M -2.47500M 2.70M -2.49414M
Total cashflows from investing activities - -0.09700M -0.06300M -0.02200M -0.56428M
Net borrowings - - - - -
Total cash from financing activities -0.11100M 30.73M 25.61M 14.35M 12.08M
Change to operating activities 0.98M -0.68200M 0.49M -1.34100M -0.24000M
Net income -16.33700M -17.07500M -15.89400M -13.63000M 33.99M
Change in cash -21.23900M 16.55M 10.81M -1.05300M -0.62368M
Begin period cash flow 33.89M 17.35M 6.53M 7.58M 8.21M
End period cash flow 12.65M 33.89M 17.35M 6.53M 7.59M
Total cash from operating activities -21.12800M -14.08900M -14.72900M -15.38300M -12.13802M
Issuance of capital stock 0.00000M 33.01M 26.19M 12.14M 8.00M
Depreciation 1.05M 1.09M 1.18M 1.27M 1.28M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - -0.18600M 0.79M 3.87M 12.08M
Other cashflows from financing activities -0.11100M -2.09400M -0.58500M 2.21M 4.08M
Change to netincome -3.10400M -0.77700M 1.89M -4.45400M -44.67135M
Capital expenditures 0.00000M 0.10M 0.06M 0.02M 0.56M
Change receivables - - - - -
Cash flows other operating - -0.59300M 0.57M -1.27100M -0.24008M
Exchange rate changes - - - - -
Cash and cash equivalents changes - 16.55M 10.81M -1.05300M -0.62368M
Change in working capital -2.97400M 2.58M -1.98500M 1.36M -2.73421M
Stock based compensation 0.95M 2.72M 1.28M 0.41M 0.44M
Other non cash items -3.81800M 0.08M 0.62M 0.08M 0.06M
Free cash flow -21.12800M -14.18600M -14.79200M -15.40500M -12.70230M

Fundamentals

  • Previous Close 0.35
  • Market Cap1.52M
  • Volume4818
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.68700M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-11.7

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
AMPE
Ampio Pharm		 - -% 0.35 - - - 0.31 0.45
NVO
Novo Nordisk A/S		 -0.37 0.29% 125.79 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 -3.3 2.60% 123.50 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 -3.06 0.76% 397.70 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd		 0.06 0.07% 90.16 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

View All

Profile

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

Ampio Pharm

373 Inverness Parkway, Englewood, CO, United States, 80112

Key Executives

Name Title Year Born
Mr. Michael A. Martino CEO & Director 1957
Dr. David Bar-Or M.D. Founder & Chairman of Scientific Advisory Board 1949
Mr. Daniel G. Stokely CPA, CPA CFO, Corp. Sec. & Treasurer 1964
Dr. Howard Levy M.B.B.Ch., M.M.M., Ph.D. Chief Medical Officer 1954
Lane Hapke VP of Manufacturing Operations NA
April Ramirez Clinical Trial Mang. NA
Laura Goldberg VP of Quality and Regulatory Operations NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).